|
[Related PubMed/MEDLINE]
Total Number of Papers: 44
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study. |
aONL, NMOSD, ON |
| 2 |
2020 |
Adverse Events and Discontinuation Rates Associated with Sirolimus Treatment in Adult Renal Transplant Patients in Latin America vs Non-Latin American Countries. |
EU/ROW, NA, SAEs, TEAEs |
| 3 |
2020 |
Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America. |
APAC, E-EUR, W-EUR |
| 4 |
2020 |
Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patients. |
DMTs, MS, PwMS |
| 5 |
2020 |
Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population. |
CT, MRI, MS, PBVL, T2LV |
| 6 |
2020 |
Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort. |
ATM, CNS, EDSS, IIF, LETM, MRI, MS, NMOSD, ON |
| 7 |
2020 |
Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort. |
EDSS, LO-NMOSD |
| 8 |
2020 |
Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure. |
VREfm |
| 9 |
2020 |
Highlights of an Expert Advisory Board on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD) in Latin America. |
AECOPD, AECOPD, COPD |
| 10 |
2020 |
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study. |
anti-TNF, APAC, CD, IBD, NICs, RME, UC |
| 11 |
2020 |
Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice. |
NMOSD |
| 12 |
2020 |
Pharmaceuticals as emerging contaminants in the aquatic environment of Latin America: a review. |
PhACs, SW, TWW, WW |
| 13 |
2020 |
Prostate Cancer in Latin America: Challenges and Recommendations. |
AHF, nmCRPC, PCa |
| 14 |
2020 |
Registration pathways to accelerate regulatory assessment of innovative medicines in Latin America. |
CPP |
| 15 |
2019 |
A review on the occurrence of companion vector-borne diseases in pet animals in Latin America. |
CVBDs |
| 16 |
2019 |
Antimicrobial Susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016). |
APAC, EUR, MDR, NA, XDR |
| 17 |
2019 |
AOSpine Global Survey: International Trends in Utilization of Magnetic Resonance Imaging/Computed Tomography for Spinal Trauma and Spinal Cord Injury across AO Regions. |
APAC, CT, EU, iSCI, MEA, MRI, NA, OR, SCI |
| 18 |
2019 |
Defining the Value of Health Technologies in Latin America: Developments in Value Frameworks to Inform the Allocation of Healthcare Resources. |
HTAi |
| 19 |
2019 |
Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin America. |
ABSSSIs, APAC, BHS, CA, E-EUR, MRSA |
| 20 |
2019 |
Latin America intensive care unit disaster preparedness: Results from a web-based attitudes and perceptions survey. |
CI, ICUs, OR |
| 21 |
2019 |
Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America. |
--- |
| 22 |
2019 |
Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016. |
APAC, EFM, NA, UTIs, VRE |
| 23 |
2019 |
The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directions. |
--- |
| 24 |
2019 |
Vaccination herd effect experience in Latin America: a systematic literature review. |
Hib, PCV, VHL |
| 25 |
2018 |
A systematic review about the epidemiology of primary progressive multiple sclerosis in Latin America and the Caribbean. |
MS, PPMS |
| 26 |
2018 |
Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America. |
APAC, CABP, E-EUR, EUR, W-EUR |
| 27 |
2018 |
Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America. |
PPMS, RRMS |
| 28 |
2018 |
Edoxaban Versus Warfarin in LatinAmerican Patients With AtrialFibrillation: The ENGAGE AF-TIMI 48 Trial. |
CI, HR, HR, HR, ICH, nLAS |
| 29 |
2018 |
Emerging Infectious Agents and Blood Safety in Latin America. |
HIV |
| 30 |
2018 |
Insulin Injection Technique Questionnaire: results of an international study comparing Brazil, Latin America and World data. |
ITQ, T1DM |
| 31 |
2018 |
The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments. |
--- |
| 32 |
2018 |
Trends in pelvic organ prolapse management in Latin America. |
POP |
| 33 |
2017 |
Access and barriers to MS care in Latin America. |
CNBD, DMTs, MS |
| 34 |
2017 |
Activity of telavancin against Gram-positive pathogens isolated from bone and joint infections in North American, Latin American, European and Asia-Pacific nations. |
APAC, BJI, MRSA, US |
| 35 |
2017 |
Application of the McDonald criteria in Latin America. |
CNS, MS |
| 36 |
2017 |
Epidemiology of neuromyelitis optica in Latin America. |
MS, NMO, SA |
| 37 |
2017 |
Multiple sclerosis epidemiology in Latin America: An updated survey. |
--- |
| 38 |
2017 |
Multiple Sclerosis in Latin Americans: Genetic Aspects. |
AIMs, GWAS, LA, MS |
| 39 |
2016 |
Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations. |
AK, C-PDT, DL-PDT, MAL |
| 40 |
2016 |
Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America. |
ACB, MIC |
| 41 |
2015 |
Patient-Reported Outcomes in Latin America: Implementation in Research and Role in Emerging HTA Systems. |
HTA, PROs |
| 42 |
2014 |
Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011). |
APAC, EMR, ESBL, USA, UTI |
| 43 |
2013 |
Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). |
ACB, AMK, ARG, BRA, C/S, CBA, COL, EC, ECU, GUA, KSP, LZD, Mex, PAN, PSA, Spn, TIG, VAN, VEN |
| 44 |
2008 |
MS in Latin America. |
MS |
|
A Search Service for Abbreviation / Long Form
